Navigation

Dermatitis atopica (Neurodermitis)

  • LPO162-1337 - ECZTEND
  • An open-label, single-arm, multi-centre, long-term extension trial to evaluate the safety and efficacy of tralokinumab in subjects with atopic dermatitis who participated in previous tralokinumab clinical trials
  • Studie läuft; Rekrutierung abgeschlossen

 

  • LPO162-1346 - ECZTRA 7
  • A randomised, double-blind, placebo-controlled, parallel-group, multi-centre, phase 3 trial investigating the effecacy, safety, and tolerabillity of tralokinumab administered in combination with topical corticosteroids to adult subjects with severe atopic dermatitis who are not adequately controlled with or have contraindications to oral cyclosporine A
  • Studie abgeschlossen

 

  • M16-047 - AD Up
  • Randomisierte, placebokontrollierte Doppelblindstudie der Phase 3 zur Untersuchung von Upadacitinib in Kombination mit topischen Kortikosteroiden bei jugendlichen und erwachsenen Studienteulnehmern mit mittelschwerer bis schwerer atopischer Dermatitis
  • Studie läuft; Rekrutierung: geschlossen

 

  • BREEZE-AD (14V-MC-JAHL)
  • A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Moderate to Severe Atopic Dermatitis
  • Studie abgeschlossen

 

  • SOLO 2 (R668-AD-1416)
  • A Phase 3, randomized, double-blind, placebo-controlled Study investigating the Efficacy an Safety and Safety of multiple Dupilumab dose regimens administered as monotherapy for Maintaining response in Patients with moderate-to-severe Atopic Dermatitis
  • Studie abgeschlossen

 

  • CAFE - R668-AD-1224 
  • A Phase 3 Study Investigating the Efficacy, Safety and Tolerability of Dupilumab abministered to adult Patients with severe Atopic Dermatitis who are not adequately controlled with or are intolerant to oral Cyclosporine A, or when this Treatment is not medically advisable
  • Studie  abgeschlossen

Letzte Aktualisierung:
06. Januar 2024

Aktualisierte Beiträge:

  • Interventionelle Studien
  • Nicht-interventionelle Studien
  • Wissenschaftliche Vorträge
  • Stellenangebote